|
|
||||||||


Departments of
*
Pathology and
Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205; and
Department of Chemistry/Biochemistry, St. Marys University, San Antonio, TX 78228
Fas-mediated apoptosis is a key mechanism for elimination of autoreactive T cells, yet loss of function mutations in the Fas signaling pathway does not result in overt T cell-mediated autoimmunity. Furthermore, mice and humans with homozygous Faslpr or Fas ligandgld mutations develop significant numbers of B220+ CD4- CD8- double-negative (DN) 
T cells (hereafter referred to as B220+ DN T cells) of poorly understood function. In this study, we show that B220+ DN T cells, whether generated in vitro or isolated from mutant mice, can suppress the ability of activated T cells to proliferate or produce IL-2, IL-10, and IFN-
. B220+ DN T cells that were isolated from either lpr or gld mice were able to suppress proliferation of autologous and syngeneic CD4 T cells, showing that suppression is Fas independent. Furthermore, restoration of Fas/Fas ligand interaction did not enhance suppression. The mechanism of suppression involves inhibition of IL-2 production and its high affinity IL-2R
-chain (CD25). Suppression also requires cell/cell contact and TCR activation of B220+ DN T cells, but not soluble cytokines. These findings suggest that B220+ DN T cells may be involved in controlling autoreactive T cells in the absence of Fas-mediated peripheral tolerance.
This article has been cited by other articles:
![]() |
T. Ishikawa, H. Yamada, A. Oyamada, F. Goshima, Y. Nishiyama, and Y. Yoshikai Protective Role of Fas-FasL Signaling in Lethal Infection with Herpes Simplex Virus Type 2 in Mice J. Virol., November 15, 2009; 83(22): 11777 - 11783. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Crispin and G. C. Tsokos Human TCR-{alpha}{beta}+ CD4- CD8- T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype J. Immunol., October 1, 2009; 183(7): 4675 - 4681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Omokaro, M. J. Desierto, M. A. Eckhaus, F. M. Ellison, J. Chen, and N. S. Young Lymphocytes with Aberrant Expression of Fas or Fas Ligand Attenuate Immune Bone Marrow Failure in a Mouse Model J. Immunol., March 15, 2009; 182(6): 3414 - 3422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Olson and S. M. Varga Fas Ligand Is Required for the Development of Respiratory Syncytial Virus Vaccine-Enhanced Disease J. Immunol., March 1, 2009; 182(5): 3024 - 3031. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Ascon, M. Ascon, S. Satpute, S. Lopez-Briones, L. Racusen, R. B. Colvin, M. J. Soloski, and H. Rabb Normal mouse kidneys contain activated and CD3+CD4-CD8- double-negative T lymphocytes with a distinct TCR repertoire J. Leukoc. Biol., December 1, 2008; 84(6): 1400 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. Zhang, Y. Ma, H. Wang, J. Arp, J. Jiang, X. Huang, K. M. He, B. Garcia, J. Madrenas, and R. Zhong Double-Negative T Cells, Activated by Xenoantigen, Lyse Autologous B and T Cells Using a Perforin/Granzyme-Dependent, Fas-Fas Ligand-Independent Pathway J. Immunol., November 15, 2006; 177(10): 6920 - 6929. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Mohamood, C. J. Trujillo, D. Zheng, C. Jie, F. M. Murillo, J. P. Schneck, and A. R. A. Hamad Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells Int. Immunol., August 1, 2006; 18(8): 1265 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rharbaoui, D. Bruder, M. Vidakovic, T. Ebensen, J. Buer, and C. A. Guzman Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues J. Immunol., February 1, 2005; 174(3): 1317 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Baron, J. Anastasi, A. Montag, D. Huo, R. M. Baron, T. Karrison, M. J. Thirman, S. K. Subudhi, R. K. Chin, D. W. Felsher, et al. The human BCL6 transgene promotes the development of lymphomas in the mouse PNAS, September 28, 2004; 101(39): 14198 - 14203. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |